免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

AmCAD-UT Detection 2.2

K 號:K180006 · 2018-08-31

決定日期2018-08-31
產品代碼LLZ
諮詢委員會RA
決定相當於

器材摘要

AmCAD-UT Detection 2.2 is the device name listed in this FDA 510(k) record. The listed applicant is Amcad Biomed Corporation. It received FDA 510(k) clearance on 2018-08-31 under 510(k) number K180006. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the AmCAD-UT Detection 2.2?

AmCAD-UT Detection 2.2 is a medical device that received FDA 510(k) clearance on 2018-08-31. The listed applicant is Amcad Biomed Corporation. The 510(k) number is K180006.

When did AmCAD-UT Detection 2.2 receive FDA 510(k) clearance?

AmCAD-UT Detection 2.2 received FDA 510(k) clearance on 2018-08-31, under 510(k) number K180006.

Who is the listed applicant for AmCAD-UT Detection 2.2?

The FDA 510(k) record lists Amcad Biomed Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AmCAD-UT Detection 2.2?

The FDA product code for AmCAD-UT Detection 2.2 is LLZ.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Amcad Biomed Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:LLZ)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑